April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Role of T-synthase in Apical Barrier Formation on Ocular Surface Epithelia
Author Affiliations & Notes
  • A. Guzman
    Schepens Eye Research Institute and Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts
  • P. Argueso
    Schepens Eye Research Institute and Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts
  • Footnotes
    Commercial Relationships  A. Guzman, None; P. Argueso, None.
  • Footnotes
    Support  NIH R01 EY014847 to PA; Alfonso Martin Escudero Foundation (Spain) to AG
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 4607. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A. Guzman, P. Argueso; Role of T-synthase in Apical Barrier Formation on Ocular Surface Epithelia. Invest. Ophthalmol. Vis. Sci. 2009;50(13):4607.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : We have previously shown that a carbohydrate-dependent association between galectin-3 and highly O-glycosylated mucins contributes to form an apical barrier at the ocular surface epithelia. T-synthase is a branchpoint enzyme responsible for the biosynthesis of the T-antigen, a key carbohydrate precursor for the elongation of mucin-type O-glycans. The purpose of this study was to determine whether T-synthase is involved in the formation of the apical barrier on the ocular surface glycocalyx.

Methods: : Human corneal-limbal epithelial (HCLE) cells were transfected with a regulatory plasmid encoding a tetracycline repressor, and subsequently infected with retroviruses containing T-synthase shRNAs. T-synthase mRNA expression and protein levels were assessed by conventional PCR and western blot, respectively. Galectin-3 and T-antigen levels on the cell surface were detected using a biotinylation assay. Barrier function was assayed by incubation of cultures with 0.1% rose bengal, and dye uptake quantified using ImageJ.

Results: : A stable tetracycline-inducible RNA interfering system to knockdown T-synthase was developed in HCLE cells. Three different shRNAs sequences efficiently reduced T-synthase mRNA expression and protein levels as compared to scramble control. Sequence 1 produced the highest decrease, with 74% mRNA and 70% protein reduction. Sequences 2 and 3 reduced T-synthase mRNA and protein by approximately 50% compared with scramble control. Cell surface T-antigen levels were also suppressed by the three sequences with sequence 1 inducing the highest repression. Concomitantly, a marked decrease of galectin-3 levels on the cell surface glycocalyx was observed in these cells. In functional assays, rose bengal penetrance significantly increased in HCLE cells stably expressing T-synthase shRNAs, especially those transfected with shRNA sequence 1, indicating loss of barrier function.

Conclusions: : These results indicate that T-synthase contributes to the formation of an apical barrier that prevents the penetrance of molecules through the epithelial cell surface glycocalyx. Manipulation of the O-glycan barrier could contribute to improving drug delivery into the cornea.

Keywords: cornea: surface mucins • glycoconjugates/glycoproteins • cornea: epithelium 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×